F4L
BMY icon

Fortune 45 LLC’s Bristol-Myers Squibb BMY Stock Holding History

Fortune 45 LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,335
Closed -$214K – 28
2023
Q2 		$214K Buy
+3,335
New +$224K 0.22% 29
2023
Q1 		– Sell
-4,146
Closed -$298K – 37
2022
Q4 		$298K Buy
4,146
+20
+0.5% +$1.51K 0.33% 32
2022
Q3 		$293K Buy
+4,126
New +$299K 0.34% 28

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Fortune 45 LLC's BMY Position: Q3 2023 in Review

Fortune 45 LLC sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,335 shares — an estimated $214K sold.

Fortune 45 LLC first reported a position in BMY in Q3 2022 and held it in 3 quarters. The position peaked at $298K in Q4 2022. 2,389 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • Fortune 45 LLC reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • Fortune 45 LLC sold 3,335 Bristol-Myers Squibb shares in Q3 2023, an estimated $214K.
  • Fortune 45 LLC first reported a position in Bristol-Myers Squibb in Q3 2022 and held it in 3 quarters.
  • Fortune 45 LLC's Bristol-Myers Squibb position peaked at $298K in Q4 2022.
  • 2,389 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Fortune 45 LLC's 13F filing for Q3 2023, filed 17 Oct 2023.